Dianthus Therapeutics, Inc. (DNTH)
NASDAQ·Healthcare·Biotechnology
$83.99
-3.64%
Mkt Cap $3.36B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 9, 2026 | $552.23K | $284.00K | -48.57% | -$0.98 | -$1.43 | -45.92% | — | — |
| Q4 2025 Nov 5, 2025 | $398.09K | $396.00K | -0.53% | -$0.86 | -$0.97 | -12.79% | — | — |
| Q3 2025 Aug 7, 2025 | $864.67K | $193.00K | -77.68% | -$0.86 | -$0.88 | -2.33% | — | — |
| Q2 2025 May 12, 2025 | $806.90K | $1.16M | +44.13% | -$0.86 | -$0.82 | +4.65% | — | — |
| Q1 2025 Mar 11, 2025 | $955.22K | $1.33M | +38.82% | -$0.85 | -$0.81 | +4.71% | — | — |
| Q4 2024 Nov 7, 2024 | $844.11K | $2.17M | +157.31% | -$0.59 | -$0.74 | -25.42% | — | — |
| Q3 2024 Aug 8, 2024 | $320.00K | $1.86M | +482.19% | -$0.50 | -$0.51 | -2.00% | — | — |
| Q2 2024 May 9, 2024 | $460.00K | $874.00K | +90.00% | -$0.43 | -$0.54 | -25.58% | — | — |
| Q1 2024 Mar 21, 2024 | $310.00K | $457.00K | +47.42% | -$1.11 | -$0.71 | +36.04% | — | — |
| Q4 2023 Nov 9, 2023 | $410.00K | $924.00K | +125.37% | -$0.51 | -$3.78 | -641.18% | — | — |
| Q3 2023 Aug 3, 2023 | — | $969.00K | — | -$0.19 | -$0.05 | +73.68% | — | — |
| Q1 2023 Mar 30, 2023 | — | $476.00K | — | -$6.40 | -$7.70 | -20.25% | — | — |
| Q4 2022 Dec 31, 2022 | — | $1.18M | — | -$4.10 | -$2.67 | +34.89% | — | — |
| Q3 2022 Sep 30, 2022 | — | $1.17M | — | -$4.64 | -$2.10 | +54.71% | — | — |
| Q3 2022 Aug 4, 2022 | — | — | — | -$5.44 | -$4.70 | +13.63% | — | — |
| Q2 2022 May 16, 2022 | — | — | — | — | -$6.24 | — | — | — |
| Q1 2022 Mar 8, 2022 | — | — | — | -$5.09 | -$5.25 | -3.15% | — | — |
| Q4 2021 Nov 4, 2021 | — | — | — | — | -$4.76 | — | — | — |
| Q3 2021 Aug 5, 2021 | — | — | — | — | -$5.04 | — | — | — |
| Q2 2021 May 6, 2021 | — | — | — | — | -$5.76 | — | — | — |